Enhancer Zeste Homolog 2 (EZH2) expression is associated with a shorter time to the first systemic therapy in follicular lymphoma

被引：0
|
作者：
Szumera-Cieckiewicz, A. [1 ]
Sokol, K. [1 ,2 ]
Rymkiewicz, G. [2 ]
Paszkiewicz-Kozik, E. [3 ]
Poleszczuk, J. [4 ]
Borysiuk, A. [2 ]
Kotarska, M. [3 ]
Walewski, J. [3 ]
Prochorec-Sobieszek, M. [5 ]
机构：
[1] Inst Haematol & Transfus Med, Dept Diagnost Haematol, Warsaw, Poland
[2] Maria Sklodowska Curie Inst Oncol Ctr, Dept Pathol & Lab Med, Gliwice, Poland
[3] Maria Sklodowska Curie Inst Oncol Ctr, Dept Lymphoid Malignancies, Gliwice, Poland
[4] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland
[5] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Pathol, Warsaw, Poland
来源：
VIRCHOWS ARCHIV | 2019年 / 475卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-13-004
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [31] Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated with Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma
    Xu, B.
    Abourbih, S.
    Sircar, K.
    Kassouf, W.
    Aprikian, A.
    Tanguay, S.
    Brimo, F.
    LABORATORY INVESTIGATION, 2013, 93 : 259A - 260A
  • [32] Enhancer of Zeste Homolog 2 (EZH2) Expression Is Associated with Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma
    Xu, B.
    Abourbih, S.
    Sircar, K.
    Kassouf, W.
    Aprikian, A.
    Tanguay, S.
    Brimo, F.
    MODERN PATHOLOGY, 2013, 26 : 259A - 260A
  • [33] Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis
    Zhang, Qi
    Dong, Peixin
    Liu, Xishi
    Sakuragi, Noriaki
    Guo, Sun-Wei
    SCIENTIFIC REPORTS, 2017, 7
  • [34] Enhancer of zeste homolog 2 (EZH2) expression in G1-G2 Pancreatic Neuroendocrine Tumor (pNET)
    Marconcini, R.
    Faviana, P.
    Campani, D.
    Galli, L.
    Antonuzzo, A.
    Falcone, A.
    Ricci, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [35] Evaluation of Immunohistochemical Expression of Enhancer of Zeste Homolog 2 (EZH2) and Its Association With Clinicopathological Variables in Carcinoma Cervix
    Priya, Aditi
    Chaurasia, Jai K.
    Pushpalatha, K.
    Panwar, Hemlata
    Yadav, Shakti K.
    Kapoor, Neelkamal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (03)
  • [36] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Changchien, Yi-Che
    Tatrai, Peter
    Papp, Gergo
    Sapi, Johanna
    Fonyad, Laszlo
    Szendroi, Miklos
    Papai, Zsuzsanna
    Sapi, Zoltan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [37] Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
    Yi-Che Changchien
    Péter Tátrai
    Gergő Papp
    Johanna Sápi
    László Fónyad
    Miklós Szendrői
    Zsuzsanna Pápai
    Zoltán Sápi
    Journal of Translational Medicine, 10
  • [38] Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo
    Sengupta, Deepanwita
    Avaritt, Nathan
    Shalin, Sara C.
    Tackett, Alan J.
    CANCER RESEARCH, 2016, 76
  • [39] Enhancer of Zeste Homolog 2 (EZH2) in COVID-19-Positive Acute Myeloid Leukemia
    Hamed, Nahla
    Gallab, Omar
    Abdelhalim, Reham
    Rezk, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S289 - S290
  • [40] The role of methyltransferase, enhancer of zeste homolog 2 (EZH2) in mouse hepatocyte and human hepatocellular carcinoma
    Bae, Woo Kyun
    Shim, Hyun Jeong
    Cho, Sang Hee
    Chung, Ik-Joo
    Park, In-Kyu
    Hennighausen, Lothar
    CANCER RESEARCH, 2015, 75
12345